Supporting Blood Cancer Clinical Trials: Predicting Study Challenges

What challenges should teams conducting blood cancer clinical trials anticipate? Learn more about common obstacles and how to overcome them.

May 26, 2022
View the Post

Ensuring Consistency in RECIST 1.1 Reads

RECIST criteria is not always reported accurately, and variability in tumor response assessment may be disastrous for measuring true treatment effect. Here’s how your CRO can support more consistent RECIST reads.

December 15, 2021
View the Post

Breast Cancer Clinical Trials: A Caregiver & Project Manager’s Perspective

Breast Cancer Clinical Trials: A Caregiver, Advocate, and Project Manager’s Perspective  “Being an advocate for my mother made a big difference,” Tamara said. “Some people might be going through this process alone, or may not be able to understand the whole disease. I feel I was fortunate to be able to put my oncology background...
November 15, 2021
View the Post

Immuno-Oncology Clinical Trial Considerations

What do you need to consider when managing/monitoring an immuno-oncology clinical trial? Download PharPoint’s fact book to learn more.

May 5, 2021
View the Post

Industry News – April 2021 – Oncology

Researchers have found a possible explanation for why many cancer drugs work in mouse models but not human, along with a new method for starving cells, and an unexpected discovery regarding transposons & blood cancers. Explore this months oncology round-up:

April 22, 2021
View the Post

Acknowledging World Cancer Day 2021

February 4th marks World Cancer Day, led by the Union for International Cancer Control (UICC). As a CRO with expertise in oncology, PharPoint Research is dedicated to uniting in the fight against cancer.

February 4, 2021
View the Post

Industry News – Oncology – January 2021

What’s new in oncology this January? We’ve rounded up information on the use of cancer microbiomes in tumors, an inhibitor drug combination for a rare form of cancer, and new clues to prostate cancer.

January 18, 2021
View the Post

Industry News – Oncology October 2020

What’s new in oncology for October 2020? We’ve rounded up information on potential cancer-reducing drugs, liquid biopsy to detect brain tumors, and new immune-like characteristics of cells.

October 21, 2020
View the Post